Live from the NIH registry
Studies recruiting near Merced right now
Top 25 of 30 recruiting studies, sorted by proximity — each links to its official registry page
Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE Trial
Plasma Cell Myeloma, RISS Stage I Plasma Cell Myeloma
Phase 3
Interventional 1,450 participants sought
Mercy Cancer Center — Merced, California (0.4 mi)
· Sponsor: ECOG-ACRIN Cancer Research Group
Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
Prostate Cancer (Adenocarcinoma)
Phase 3
Interventional 830 participants sought
Mercy Cancer Center — Merced, California (0.4 mi)
· Sponsor: Canadian Cancer Trials Group
Cognitive Training for Cancer Related Cognitive Impairment in Breast Cancer Survivors
Breast Cancer, Cognitive Impairments
N/A
Interventional 386 participants sought
Mercy Cancer Center — Merced, California (0.4 mi)
· Sponsor: NRG Oncology
Vismodegib, FAK Inhibitor GSK2256098, Capivasertib, and Abemaciclib in Treating Patients With Progressive Meningiomas
Intracranial Meningioma, Recurrent Meningioma
Phase 2
Interventional 124 participants sought
Mercy Cancer Center — Merced, California (0.4 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Trastuzumab
Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8
Phase 3
Interventional 1,524 participants sought
Mercy Cancer Center — Merced, California (0.4 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Multiple conditions
N/A
Observational 2,000 participants sought
Mercy Cancer Center — Merced, California (0.4 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
Treatment of Radiation and Cisplatin Induced Toxicities with Tempol
Mucositis, Nephrotoxicity
Phase 2
Interventional 120 participants sought
Mercy Medical Center — Merced, California (0.4 mi)
· Sponsor: Matrix Biomed, Inc.
A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart
Heart Failure
Phase 3
Interventional 4,200 participants sought
Merced Vein and Vascular Center — Merced, California (0.4 mi)
· Sponsor: Boehringer Ingelheim
mFOLFIRINOX Versus mFOLFOX With or Without Nivolumab for the Treatment of Advanced, Unresectable, or Metastatic HER2 Negative Esophageal, Gastroesophageal Junction, and Gastric Adenocarcinoma
Advanced Esophageal Adenocarcinoma, Advanced Gastric Adenocarcinoma
Phase 3
Interventional 382 participants sought
Mercy Cancer Center — Merced, California (0.4 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
Breast Cancer
Phase 3
Interventional 3,960 participants sought
Mercy Cancer Center — Merced, California (0.4 mi)
· Sponsor: NRG Oncology
Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery
Head and Neck Squamous Cell Carcinoma, Hypopharyngeal Squamous Cell Carcinoma
Phase 2
Interventional 189 participants sought
Mercy Cancer Center — Merced, California (0.4 mi)
· Sponsor: ECOG-ACRIN Cancer Research Group
RA-PRO PRAGMATIC TRIAL
Rheumatoid Arthritis
Phase 3
Interventional 924 participants sought
Turlock Arthritis & Osteoporosis Center, — Turlock, California (24.1 mi)
· Sponsor: University of Alabama at Birmingham
The Golazo® Peripheral Atherectomy System for a Safe and Effective Atherectomy (GREAT Trial)
Peripheral Arterial Disease
N/A
Interventional 159 participants sought
Merced Vascular — Merced, California (0.4 mi)
· Sponsor: Avantec Vascular
Evaluating Whether an Educational Website Called Current Together After Cancer (CTAC) Improves Follow-up Care for Colorectal Cancer Survivors
Colorectal Cancer Stage II, Colorectal Cancer Stage III
Phase 3
Interventional 1,057 participants sought
Mercy Cancer Center — Merced, California (0.4 mi)
· Sponsor: SWOG Cancer Research Network
Immune Checkpoint Inhibitor Toxicity Risk Prediction in Solid Tumors
Malignant Solid Neoplasm
N/A
Observational 2,062 participants sought
Mercy Cancer Center — Merced, California (0.4 mi)
· Sponsor: SWOG Cancer Research Network
Studying Chemotherapy With or Without Panitumumab for Unresectable, Locally Advanced, or Metastatic Pancreatic Cancer Without KRAS Mutations
Locally Advanced Pancreatic Adenocarcinoma, Metastatic Pancreatic Adenocarcinoma
Phase 3
Interventional 94 participants sought
Mercy Cancer Center — Merced, California (0.4 mi)
· Sponsor: SWOG Cancer Research Network
Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging
Biochemically Recurrent Prostate Carcinoma, Metastatic Prostate Carcinoma
Phase 3
Interventional 804 participants sought
Mercy Cancer Center — Merced, California (0.4 mi)
· Sponsor: ECOG-ACRIN Cancer Research Group
Family Communications After Genetic Testing
Colon Adenocarcinoma, Colorectal Adenocarcinoma
N/A
Interventional 4,186 participants sought
Mercy Cancer Center — Merced, California (0.4 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
Improving Adolescent and Young Adult Self-Reported Data in ECOG-ACRIN Trials
Breast Cancer, NOS, CNS Primary Tumor, NOS
N/A
Interventional 400 participants sought
Mercy Cancer Center — Merced, California (0.4 mi)
· Sponsor: Eastern Cooperative Oncology Group
Studying the PAGODA Algorithm for Chemotherapy Dose Changes to Prevent Unplanned Treatment Delays
Ampulla of Vater Carcinoma, Appendix Carcinoma
N/A
Interventional 420 participants sought
Mercy Cancer Center — Merced, California (0.4 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
Fallopian Tube Endometrioid Adenocarcinoma, Fallopian Tube High Grade Serous Adenocarcinoma
Phase 3
Interventional 880 participants sought
Mercy Cancer Center — Merced, California (0.4 mi)
· Sponsor: NRG Oncology
Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering Myeloma
Smoldering Plasma Cell Myeloma
Phase 3
Interventional 288 participants sought
Mercy Cancer Center — Merced, California (0.4 mi)
· Sponsor: ECOG-ACRIN Cancer Research Group
Testing an Enhanced Digital Delivery Model for Inherited Cancer Genetic Testing in Young Adults With Cancer
Miscellaneous Neoplasm, Nos, Non-Neoplastic Condition, Nos
N/A
Interventional 535 participants sought
Mercy Cancer Center — Merced, California (0.4 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
Shorter Chemo-Immunotherapy Without Anthracycline Drugs for Early-Stage Triple Negative Breast Cancer
Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8
Phase 3
Interventional 2,400 participants sought
Mercy Cancer Center — Merced, California (0.4 mi)
· Sponsor: SWOG Cancer Research Network
Mobile Health for Adherence in Breast Cancer Patients
Anatomic Stage IV Breast Cancer AJCC v8, Breast Carcinoma
N/A
Interventional 410 participants sought
Mercy Cancer Center — Merced, California (0.4 mi)
· Sponsor: ECOG-ACRIN Cancer Research Group